Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen

We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hung, Chien-Fu, He, Liangmei, Juang, Jeremy, Lin, Tzyy-Jye, Ling, Morris, Wu, T.-C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2002
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC135982/
https://ncbi.nlm.nih.gov/pubmed/11861834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.6.2676-2682.2002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge